Sheehy Douglas T.

CIK 00014886372 companiesREDWOOD CITY, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001488637

Recent Transactions

50 trades

Disposition to Issuer
Aimmune Therapeutics, Inc.
Stock Option (right to buy)
2020-10-13$0.43/sh−75,000→ 0 total
Disposition to Issuer
Aimmune Therapeutics, Inc.
Stock Option (right to buy)
2020-10-13$14.87/sh−67,500→ 0 total
Disposition to Issuer
Aimmune Therapeutics, Inc.
Stock Option (right to buy)
2020-10-13$10.69/sh−67,500→ 0 total
Disposition to Issuer
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2020-10-13$34.50/sh−36,875→ 0 total
Disposition to Issuer
Aimmune Therapeutics, Inc.
Stock Option (right to buy)
2020-10-13$10.78/sh−75,000→ 0 total
Disposition to Issuer
Aimmune Therapeutics, Inc.
Stock Option (right to buy)
2020-10-13$21.55/sh−22,361→ 0 total
Disposition from Tender
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2020-10-10$34.50/sh−47,450→ 0 total
Exercise/Conversion
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2020-10-05$12.95/sh+30,888→ 85,426 total
Exercise/Conversion
Aimmune Therapeutics, Inc.
Stock Option (Right to Buy)
2020-10-05−30,888→ 22,361 total
Tax Payment
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2020-09-15$34.25/sh−840→ 54,538 total
Award
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2020-05-10+2,420→ 55,378 total
Tax Payment
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2020-03-02$23.81/sh−3,960→ 52,958 total
Award
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2020-02-28−11,250→ 56,918 total
Award
Aimmune Therapeutics, Inc.
Stock Option (right to buy)
2020-02-28−67,500→ 67,500 total
Exercise/Conversion
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2020-01-16$12.95/sh+400→ 46,068 total
Sale
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2020-01-16$37.00/sh−400→ 45,668 total
Exercise/Conversion
Aimmune Therapeutics, Inc.
Stock Option (right to buy)
2020-01-16−400→ 53,249 total
Exercise/Conversion
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2019-12-26$12.95/sh+10,000→ 55,668 total
Sale
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2019-12-26$33.03/sh−10,000→ 45,668 total
Exercise/Conversion
Aimmune Therapeutics, Inc.
Stock Option (right to buy)
2019-12-26−10,000→ 53,649 total
Tax Payment
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2019-03-01$24.30/sh−2,883→ 42,785 total
Award
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2019-02-22+12,500→ 45,668 total
Award
Aimmune Therapeutics, Inc.
Stock Option (right to buy)
2019-02-22+75,000→ 75,000 total
Sale
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2018-05-22$33.00/sh−1,648→ 33,079 total
Exercise/Conversion
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2018-05-22$12.95/sh+1,648→ 34,727 total
Exercise/Conversion
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2018-05-22$12.95/sh+1,648→ 34,727 total
Sale
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2018-05-22$33.00/sh−1,648→ 33,079 total
Exercise/Conversion
Aimmune Therapeutics, Inc.
Stock Option (right to buy)
2018-05-22−1,648→ 65,297 total
Exercise/Conversion
Aimmune Therapeutics, Inc.
Stock Option (right to buy)
2018-05-22−1,648→ 63,649 total
Sale
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2018-03-05$36.60/sh−700→ 32,500 total
Exercise/Conversion
Aimmune Therapeutics, Inc.
Stock Option (right to buy)
2018-03-05−1,648→ 66,945 total
Exercise/Conversion
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2018-03-05$19.63/sh+1,875→ 34,375 total
Sale
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2018-03-05$37.00/sh−1,875→ 32,500 total
Exercise/Conversion
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2018-03-05$12.95/sh+1,648→ 34,148 total
Sale
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2018-03-05$35.52/sh−948→ 33,200 total
Exercise/Conversion
Aimmune Therapeutics, Inc.
Stock Option (right to buy)
2018-03-05−1,875→ 67,500 total
Award
Aimmune Therapeutics, Inc.
Stock Option (right to buy)
2018-03-04+75,000→ 75,000 total
Award
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2018-03-04+32,500→ 32,500 total
Exercise/Conversion
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2018-02-05$12.95/sh+1,648→ 1,648 total
Sale
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2018-02-05$35.87/sh−1,648→ 0 total
Exercise/Conversion
Aimmune Therapeutics, Inc.
Stock Option(right to buy)
2018-02-05−1,648→ 68,593 total
Sale
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2018-01-24$38.15/sh−1,875→ 0 total
Exercise/Conversion
Aimmune Therapeutics, Inc.
Stock Option (right to buy)
2018-01-24−1,875→ 69,375 total
Exercise/Conversion
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2018-01-24$19.63/sh+1,875→ 1,875 total
Exercise/Conversion
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2017-12-26$19.63/sh+1,875→ 1,875 total
Exercise/Conversion
Aimmune Therapeutics, Inc.
Stock Option (right to buy)
2017-12-26−1,875→ 71,250 total
Sale
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2017-12-26$39.44/sh−1,875→ 0 total
Exercise/Conversion
Aimmune Therapeutics, Inc.
Stock Option (right to buy)
2017-12-04−1,906→ 71,889 total
Exercise/Conversion
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2017-12-04$12.95/sh+1,906→ 1,906 total
Sale
Aimmune Therapeutics, Inc.
Common Stock, $0.0001 par value
2017-12-04$38.66/sh−1,906→ 0 total

Companies

Recent Filings

Address

C/O CODEXIS, INC. 200 PENOBSCOT DRIVE

REDWOOD CITY, CA, 94063

View on SEC.gov